Encouraging earnings results from 2 SPACs on tap: Voltus, Swvl

by | Mar 21, 2022

Encouraging Q4 results from 2 SPACs on tap: Voltus and Swvl . And all the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

PPGH / Gogoro upsizes PIPE

Poema Global Holdings Corp. (PPGH) / Gogoro upsized its PIPE by $37.5M to total of $295M. Transaction is expected to close in early April. Taiwanese battery swapping tech supplier Gogoro is expected to trade as GGR. Vote is 3/31. Gogoro announced it had exceeded its prior 2021 revenue projection of $326.9M by approximately 10%. The company says it’s tracking well against its previous 2022 revenue projection of $500.2M. 

SCLE / Voltus reports Q4 results; investor update tomorrow

Voltus, which is expected to merge Broadscale Acquisition Corp. (SCLE), reported Q4 and full year results. The company will hold its investor day tomorrow. The merger is on track to close in Q2 2022.

GMBT / Swvl reports Q4 results

Dubai-based ride sharing platform Swvl, which is expected to merger with women-led SPAC Queen’s Gambit (GMBT), reported Q4 results. The company reported 12.6 million in bookings for Q4 2021 (+92% YoY), outperforming full-year projections by 17%. Swvl’s bus-hailing service enables users to make intra-state journeys by booking seats on buses running a fixed route– saving money and reducing emissions. The company offers inter-city rides, car ride-sharing, and corporate services across the 10 cities it operates in across Africa and the Middle East. Merger vote 3/30.

Elsewhere in SPACs

  • Ackrell SPAC Partners I Corp. (ACKIU) extends. Confirms $0.10 trust funding and June-22 deadline. $10.20 in trust. The SPAC has only a single 3-month extension option left.
  • Viveon Health Acquisition Corp. (VHAQ), which has a deal announcement with regenerative esthetics company Suneva Medical— confirmed its extension to 6/28, and added $720k to trust. VHAQ can extend (without a vote) in 1-month increments for up to 6 months, or 12/28.

SPAC Calendar

SPAC Deal Votes

  • Mar 22 | TWNT –> TERRAN ORBITAL Corp
  • Mar 29 | HTPA –> Packable
  • Mar 31 | HLXA –> MoonLake Immunotherapeutics AG

SPAC Extension Votes

  • AMAO extension vote today. March 22 liquidation date.
  • Mar 18 | BRLI
  • Mar 22 | THCA

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – December 10, 2024

Jackson Acquisition II $200M IPO (Jackson I Liquidated). APXI Shareholders Approve Extension w/ 5M Redemptions. HCVI Merger Amendment. SLAMF Vote Adjourned and IVCB Vote Postponed. 

Daily SPAC Update – December 9, 2024

TCHP + Coincheck Deal Approved. GLLI, INAQ, ESHA Shareholders Approve Extensions. DP Cap Acquisition  (DPCS) Dismisses Accountant. SLAM and BRKH Extension Votes.

Daily SPAC Update – December 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.